We have previously demonstrated increased bone expression of TXNIP in patients with endogenous Cushing's syndrome (CS), and we hypothesized that TXNIP could contribute to the dysregulated glucose metabolism in CS. This evidence concerns the gene TXNIP and Cushing syndrome due to macronodular adrenal hyperplasia.